Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for PACB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 -0.255M
March 31, 2026 -1.437M
December 31, 2025 0.00
September 30, 2025 -1.469M
June 30, 2025 0.00
March 31, 2025 -1.959M
December 31, 2024 0.00
September 30, 2024 -0.812M
June 30, 2024 0.00
March 31, 2024 -6.891M
December 31, 2023 -0.936M
September 30, 2023 -4.562M
June 30, 2023 -2.586M
March 31, 2023 -196.44M
December 31, 2022 -1.247M
September 30, 2022 -3.543M
June 30, 2022 -0.848M
March 31, 2022 -5.592M
December 31, 2021 -1.684M
September 30, 2021 -299.90M
June 30, 2021 -2.968M
March 31, 2021 -22.10M
December 31, 2020 -125.88M
September 30, 2020 -107.14M
June 30, 2020 -0.628M
Date Value
March 31, 2020 -0.199M
December 31, 2019 -0.131M
September 30, 2019 -0.327M
June 30, 2019 -1.40M
March 31, 2019 -6.69M
December 31, 2018 -5.279M
September 30, 2018 -66.52M
June 30, 2018 0.094M
March 31, 2018 -35.47M
December 31, 2017 -0.096M
September 30, 2017 -2.408M
June 30, 2017 -67.40M
March 31, 2017 -3.408M
December 31, 2016 -0.20M
September 30, 2016 -3.027M
June 30, 2016 -32.74M
March 31, 2016 -29.96M
December 31, 2015 -29.56M
September 30, 2015 -2.481M
June 30, 2015 -1.983M
March 31, 2015 -2.434M
December 31, 2014 -17.90M
September 30, 2014 -0.75M
June 30, 2014 -0.38M
March 31, 2014 -22.96M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Illumina, Inc. 128.00M
Agilent Technologies, Inc. 44.00M
Bio-Rad Laboratories, Inc. 27.30M
Danaher Corp. 885.00M
Thermo Fisher Scientific, Inc. 1.00B